---
figid: PMC4817351__nihms754618f8
figlink: /pmc/articles/PMC4817351/figure/F8/
number: F8
caption: Molecular pathways of proliferation, survival and senescence. Extracellular
  growth factors trigger the dimerisation of receptor tyrosine kinases, leading to
  autophosphorylation and activation of intracellular signalling cascades such as
  the MAPK/ERK or the PI3K/AKT/mTOR pathway. Among a variety of other functions, these
  signalling pathways increase cell proliferation and survival. Many of the components,
  especially of the MAPK/ERK pathway, show genetic aberrations in spitzoid melanocytic
  tumours, which lead to a constitutive pathway activation. However, the activation
  of oncogenic pathways epigenetically de-represses the CDKN2A locus, encoding the
  proteins p16 and p14. Oncogene activation and cell proliferation may also lead to
  telomere shortening and increased concentrations of reactive oxygen species (ROS),
  which causes a DNA-damage response and activates p53 and p21. The signalling cascades
  of the p16 and p53 pathway converge on the tumour suppressor retinoblastoma (Rb)
  and on cell cycle inhibitors. After initial cell proliferation, these signalling
  pathways cause a durable proliferative arrest, termed senescence.
pmcid: PMC4817351
papertitle: Genomic aberrations in spitzoid tumours and their implications for diagnosis,
  prognosis and therapy.
reftext: Thomas Wiesner, et al. Pathology. ;48(2):113-131.
pmc_ranked_result_index: '1442'
pathway_score: 0.9771199
filename: nihms754618f8.jpg
figtitle: Molecular pathways of proliferation, survival and senescence
year: ''
organisms: Homo sapiens
ndex: d3e6fd2e-debc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4817351__nihms754618f8.html
  '@type': Dataset
  description: Molecular pathways of proliferation, survival and senescence. Extracellular
    growth factors trigger the dimerisation of receptor tyrosine kinases, leading
    to autophosphorylation and activation of intracellular signalling cascades such
    as the MAPK/ERK or the PI3K/AKT/mTOR pathway. Among a variety of other functions,
    these signalling pathways increase cell proliferation and survival. Many of the
    components, especially of the MAPK/ERK pathway, show genetic aberrations in spitzoid
    melanocytic tumours, which lead to a constitutive pathway activation. However,
    the activation of oncogenic pathways epigenetically de-represses the CDKN2A locus,
    encoding the proteins p16 and p14. Oncogene activation and cell proliferation
    may also lead to telomere shortening and increased concentrations of reactive
    oxygen species (ROS), which causes a DNA-damage response and activates p53 and
    p21. The signalling cascades of the p16 and p53 pathway converge on the tumour
    suppressor retinoblastoma (Rb) and on cell cycle inhibitors. After initial cell
    proliferation, these signalling pathways cause a durable proliferative arrest,
    termed senescence.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDKN2A
  - PIK3CD
  - MAPK3
  - AKT1
  - MAP2K2
  - AKT2
  - AKT3
  - PIK3CB
  - ARAF
  - HRAS
  - KRAS
  - MDM2
  - PIK3CG
  - PIK3R3
  - PIK3R5
  - MAPK1
  - PIK3CA
  - CDK6
  - CDK4
  - ALK
  - MAP2K1
  - NRAS
  - RET
  - NTRK1
  - PIK3R4
  - MTOR
  - RAF1
  - PTEN
  - MET
  - BRAF
  - CDK2
  - PIK3R6
  - ROS1
  - TP53
  - tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: CDKN2A
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: (ALK,
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (ALK,NTRK1,RET,ROS1,MET)
  symbol: RET
  source: hgnc_symbol
  hgnc_symbol: RET
  entrez: '5979'
- word: NTRK1,
  symbol: NTRK1
  source: hgnc_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: (ALK,NTRK1,RET,ROS1,MET)
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: (ALK,NTRK1,RET,ROS1,MET)
  symbol: ROS1
  source: hgnc_symbol
  hgnc_symbol: ROS1
  entrez: '6098'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
chemicals:
- word: tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4817351__F8
redirect_from: /figures/PMC4817351__F8
figtype: Figure
---
